LC
Laura Chico Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
51
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
86.7%
Neutral
13.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Consumer Discretionary
Residential Construction
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $13 |
9%
upside
| 1 | +79% |
0
%
| 15 Oct ‘25 4 days ago |
|
|
|
Outperform
Maintained
| $11 |
162%
upside
| 1 | +32% |
0
%
| 30 Sep ‘25 19 days ago |
|
|
|
Outperform
Maintained
| $8 |
64%
upside
| 2 | +9% |
0
%
| 30 Sep ‘25 19 days ago |
|
|
|
Outperform
Maintained
| $44 |
23%
upside
| 2 | +15% |
0
%
| 12 Sep ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $48 |
0%
upside
| 1 | +55% |
0
%
| 9 Sep ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $18 |
92%
upside
| 1 | -0.09% |
0
%
| 14 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $14 |
138%
upside
| 1 | +29% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $22 |
34%
downside
| 1 | +148% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $43 |
3%
upside
| 1 | +22% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $32 |
17%
upside
| 1 | +14% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $5 |
128%
upside
| 1 | +29% |
0
%
| 6 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $14 |
178%
upside
| 1 | +15% |
0
%
| 5 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $141 |
1%
upside
| 1 | +4% |
0
%
| 31 Jul ‘25 2 months ago |
|